Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Evaluating a Contactless Monitor for Blood Pressure at Home

Official title: VISION-Real World Evaluation

Run by Xim Limited · NCT06325384 · Data updated 2026-11-12

This study is testing whether a new contactless blood pressure monitor works as well as traditional cuffs for people with high blood pressure who are managing their condition at home.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment500 (estimated)
SponsorXim Limited
Industry-sponsored
Locations1 site (London)
StatusRecruiting
StartedFebruary 10, 2025
Main results expectedOctober 31, 2025
Study endsDecember 31, 2025
Registry record updatedApril 3, 2025
Trial IDNCT06325384 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a clinical diagnosis of uncontrolled hypertension.

Probably not a fit

Patients with stage III hypertension or significant arrhythmias may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares the effectiveness of a contactless vital signs monitor, Lifelight®, with traditional blood pressure cuffs for home monitoring in patients with uncontrolled hypertension. Participants aged 18 and older will be recruited from hypertension clinics and randomly assigned to use either the Lifelight® device or a standard BP cuff. Over six months, they will record their blood pressure readings and adherence to the monitoring schedule, while also tracking healthcare resource use and feedback on their monitoring method. The study aims to assess the feasibility and clinical outcomes of these two monitoring approaches.

Why it matters

Potential benefit: If successful, this study could provide a more convenient and effective method for patients to monitor their blood pressure at home.

How similar studies have gone: Other studies have shown promise in using innovative monitoring technologies for hypertension management, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Established diagnosis of hypertension
* Uncontrolled hypertension defined as office blood pressure ≥140/90mmHg.
* Patients who are pharmacologically treated for their hypertension should have been on stable medication for at least 4 weeks.
* Ability to read, write and understand English to complete the study.
* Capacity to give free, valid informed consent.
* A compatible device that supports Lifelight®, as per xim Ltd.'s constantly updating list of compatible devices. If this is not possible, xim Ltd, might provide a similar device for the purpose of the study.

Exclusion Criteria:

* Patients with stage III hypertension with office blood pressure ≥180/120mmHg or it is unsafe to keep them in the study, in the opinion of the investigators.
* Individuals with diagnosed atrial fibrillation.
* Patients with significant arrhythmias such as SVT (Supraventricular tachycardia) or any rhythm that has significant impact on their BP, poor perfusion, pregnancy, pre-eclampsia, deformities or abnormalities which may prevent proper application of a BP cuff, or skin disorders (anaemia, jaundice, rosacea, psoriasis, acute acne, and erythropoietic protoporphyria)
* Participants who are unwilling to undertake self-monitoring or lacking capacity.
* Partners or spouses of individuals already randomised in the trial
* Patients on dialysis or known ESRD (End-stage kidney disease)
* Patients on active cancer treatment
* Terminally ill patients
* Patients who cannot tolerate sitting for up to one hour.

Where it's running

  • William Harvey Heart Centre, Queen Mary Queen Mary University of London, Charterhouse Square,
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.